French Sanofi expands its mRNA with a firm purchase in the United States – .

French Sanofi expands its mRNA with a firm purchase in the United States – .

Paris (AFP)

French pharmaceutical giant Sanofi, which has fallen behind rivals in the development of next-generation mRNA vaccines against Covid-19, announced on Tuesday that it had bought a US technology company.

Sanofi will acquire Translate Bio, with whom it is working to develop a Covid mRNA jab, for $ 3.2 billion (2.7 billion euros), the company said in a statement.

Sanofi has been left behind in the race to release a Covid-19 vaccine in 2020, as rivals Pfizer-BioNTech and Moderna used pioneering mRNA technology to develop jabs in record time.

At the end of June, it announced that it would invest two billion euros in technology by creating a “center of excellence” employing 400 people in its laboratories in the American city of Cambridge and Marcy-L’Etoile near the city. Frenchwoman from Lyon.

Messenger RNA technology works by providing human cells with the genetic instructions to make a coronavirus surface protein, which trains the immune system to recognize the real virus.

The manufacture of a traditional vaccine is a longer process which normally involves the development of a weakened form of a pathogen.

Sanofi, which first took the traditional route, is still in the race to regain ground in the colossal market for Covid jabs.

The European Medicines Agency did not start a “continuous review” of the Sanofi coronavirus vaccine, developed with the British company GSK, until July 20.

Sanofi, which is working on the development of an mRNA vaccine with Translate Bio, based in Lexington, Mass., Said it was betting on the new technology beyond the coronavirus pandemic.

“Our goal is to unlock the potential of mRNA in other strategic areas such as immunology, oncology and rare diseases in addition to vaccines,” said Sanofi CEO Paul Hudson in a communicated.

Sanofi is not the only one with such ambitions.

Germany’s BioNTech, which developed the coronavirus vaccine with US giant Pfizer, announced in July its intention to start testing a malaria vaccine using breakthrough mRNA technology.


Please enter your comment!
Please enter your name here